Cooperation between VEGF and beta3 integrin during cardiac vascular development

Blood. 2007 Mar 1;109(5):1962-70. doi: 10.1182/blood-2005-10-038893. Epub 2006 Oct 24.

Abstract

In the developing myocardium, vascular endothelial growth factor (VEGF)-dependent neovascularization occurs by division of existing vessels, a process that persists for several weeks following birth. During this remodeling phase, mRNA expression of beta3 integrin in the heart decreases significantly as vessel maturation progresses. However, in male mice lacking beta3, coronary capillaries fail to mature and continue to exhibit irregular endothelial thickness, endothelial protrusions into the lumen, and expanded cytoplasmic vacuoles. Surprisingly, this phenotype was not seen in female beta3-null mice. Enhanced VEGF signaling contributes to the beta3-null phenotype, because these vessels can be normalized by inhibitors of VEGF or Flk-1. Moreover, intravenous injection of VEGF induces a similar angiogenic phenotype in hearts of adult wild-type mice. These findings show a clear vascular phenotype in the hearts of mice lacking beta3 and suggest this integrin plays a critical role in coronary vascular development and the vascular response to VEGF.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cardiovascular System / growth & development*
  • Cardiovascular System / metabolism*
  • Cardiovascular System / ultrastructure
  • Female
  • Integrin beta3 / genetics
  • Integrin beta3 / metabolism*
  • Male
  • Mice
  • Microscopy, Electron, Scanning
  • Phenotype
  • RNA, Messenger / genetics
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism*
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism

Substances

  • Integrin beta3
  • RNA, Messenger
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor Receptor-2